Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
Inflammation-mediated lung injury in severe cases of infection with SARS-CoV-2, the aetiological agent of Coronavirus disease 2019 (COVID-19), can lead to respiratory failure and death, and therapies that block or ameliorate lung injury-associated inflammatory “cytokine storms” and progression to ac...
Guardado en:
Autores principales: | Zhang Jian, Tian Zigang, Feng Lina, Yang Zhongming, Zou Bo, Li Kun, Zhang Yingliang, Wang Yaguo, Fleming Joy, Cui Wenyu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/671b91315d4d43a8b36bb1ed9e874ba6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Respiratory epithelium: Place of entry and / or defense against SARS-CoV-2 virus
por: Leštarević Snežana, et al.
Publicado: (2021) -
Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status
por: Nitin Saksena, et al.
Publicado: (2021) -
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021) -
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
por: Wiktoria Feret, et al.
Publicado: (2021) -
CLINICAL PROFILES AND OUTCOMES OF PATIENTS ADMITTED WITH MODERATE TO CRITICAL CORONAVIRUS DISEASE 2019 (COVID-19)
por: Mehmood Hussain
Publicado: (2021)